ESM

Trademark usage description

chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, i Read More

Classification Information

Class [005]
Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic diseases, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic diseases, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease;

Classification kind code

Class [042]
Pharmaceutical research and development services; scientific research in the fields of oncology, immuno-oncology, immunotherapy, metabolic diseases, skin diseases, viral diseases, hormonal related diseases, musculoskeletal diseases, and neurological diseases and information, advisory and consultancy services relating to the aforesaid;

Classification kind code

Mark Details

Serial Number

1849113

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 6^th Dec 2019	Approved
Submitted for opposition 67 on 16^th Jul 2019	Agent Name Changed
Submitted for opposition 48 on 20^th Jun 2019	Agent Changed
Submitted for opposition 67 on 20^th Jun 2019	Agent Name Changed
Submitted for opposition 12 on 11^th Feb 2019	Extension of Time
Submitted for opposition 22 on 2^th Aug 2018	Search Recorded
Submitted for opposition 20 on 2^th Aug 2018	Examiner's First Report
Submitted for opposition 31 on 27^th Jul 2017	Formalized
Submitted for opposition 1 on 26^th Jul 2017	Created
Submitted for opposition 30 on 25^th Jul 2017	Filed